- Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethy…
Number of the records: 1  

Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection

  1. TitleCombination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection / Z. J. Liu ... [et al.]
    Another responsib. Liu, Z. J. (Author)
    Translated titleKombinácia hypometylácie LINE-1 a hypermetylácie promótora RASSF1A DNA v sére je neinvazívny, prognostický biomarker pre včasnú recidívu hepatocelulárneho karcinómu po kuratívnej resekcii
    Phys.des.ilustr., grafy, tab.
    NoteBibliogr. odkazy
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 64, no. 5 (2017), s. 795-802
    Call numberC 720
    MeSH Subject karcinóm hepatocelulárny - chirurgia - genetika - krv
    gény supresorové nádorové
    oblasti promótorové, v genetike
    metylácia DNA
    recidíva nádoru, lokálna
    biomarkery nádorové
    analýza prežívania
    prognóza
    Keywords LINE-1 hypometylácia * RASSF1A hypermetylácia
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.